GLP-1s for Menopause (Ep.67)

About this video

In this short clip Seeds explains his preference for gradual change in peri- and postmenopausal patients, arguing the body resists abrupt shifts in diet or routine. He presents GLP-1 medicines as a favored early step because, he claims, they act on several pathways at once — food-related preoccupation, inflammation and upstream metabolic function. Seeds says some patients he has seen drop clothing sizes from reduced inflammation even without major scale change, and that improving metabolism first can make later hormone therapy more appropriate. Co-hosts add that a tangible early win helps patients trust and engage with a longer process.

Key takeaways

• Seeds favors moving metabolic levers slowly rather than making abrupt, unsustainable changes
• Seeds claims GLP-1s are useful in menopause care because they address several pathways together
• Visible early progress is framed as important for patient trust and buy-in
• Seeds presents metabolic preparation as a reason to sequence hormone therapy later, not first
• Inflammation, not weight alone, is presented as a meaningful marker of progress

Episode details: published July 8, 2026 · 253 views · 2:10 long. Summary written by Self Growth Videos from the episode itself. The peptide and cellular-medicine concepts described are Dr. William Seeds’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: the SSRP Institute sells clinician certification in peptide therapy.

← Previous: Immune Support, PMDD & Retatrutide Metabolic Flexibility #health #peptides · Next: Define Mitochondrial Biogenesis #podcast #peptides →

All Dr. William Seeds videos · Dr. William Seeds profile · SSRP Institute (official site)